Iseult Lynch

Author PubWeight™ 80.02‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc Natl Acad Sci U S A 2007 7.50
2 Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci U S A 2008 5.76
3 Detailed identification of plasma proteins adsorbed on copolymer nanoparticles. Angew Chem Int Ed Engl 2007 3.41
4 Nucleation of protein fibrillation by nanoparticles. Proc Natl Acad Sci U S A 2007 3.23
5 Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. J Am Chem Soc 2011 3.19
6 What the cell "sees" in bionanoscience. J Am Chem Soc 2010 3.07
7 Protein-nanoparticle interactions: opportunities and challenges. Chem Rev 2011 2.34
8 The evolution of the protein corona around nanoparticles: a test study. ACS Nano 2011 2.05
9 Protein-nanoparticle interactions: What does the cell see? Nat Nanotechnol 2009 2.00
10 Inhibition of amyloid beta protein fibrillation by polymeric nanoparticles. J Am Chem Soc 2008 1.60
11 Complete high-density lipoproteins in nanoparticle corona. FEBS J 2009 1.47
12 Quantification of nanoparticle uptake by cells using an unbiased sampling method and electron microscopy. Nanomedicine (Lond) 2011 1.43
13 Designing the nanoparticle-biomolecule interface for "targeting and therapeutic delivery". J Control Release 2012 1.41
14 Exposure assessment: recommendations for nanotechnology-based pesticides. Int J Occup Environ Health 2011 1.39
15 Minimal analytical characterization of engineered nanomaterials needed for hazard assessment in biological matrices. Nanotoxicology 2010 1.38
16 Systematic investigation of the thermodynamics of HSA adsorption to N-iso-propylacrylamide/N-tert-butylacrylamide copolymer nanoparticles. Effects of particle size and hydrophobicity. Nano Lett 2007 1.37
17 Effects of transport inhibitors on the cellular uptake of carboxylated polystyrene nanoparticles in different cell lines. PLoS One 2011 1.36
18 Experimental and theoretical comparison of intracellular import of polymeric nanoparticles and small molecules: toward models of uptake kinetics. Nanomedicine 2011 1.35
19 Serum heat inactivation affects protein corona composition and nanoparticle uptake. Biomaterials 2010 1.34
20 Emerging methods and tools for environmental risk assessment, decision-making, and policy for nanomaterials: summary of NATO Advanced Research Workshop. J Nanopart Res 2008 1.28
21 Reproducible comet assay of amorphous silica nanoparticles detects no genotoxicity. Nano Lett 2008 1.25
22 Quantitative assessment of the comparative nanoparticle-uptake efficiency of a range of cell lines. Small 2011 1.25
23 Time and space resolved uptake study of silica nanoparticles by human cells. Mol Biosyst 2010 1.25
24 Fate and effects of CeO2 nanoparticles in aquatic ecotoxicity tests. Environ Sci Technol 2009 1.20
25 Nanotoxicology: nanoparticles reconstruct lipids. Nat Nanotechnol 2009 1.19
26 Dual effect of amino modified polystyrene nanoparticles on amyloid β protein fibrillation. ACS Chem Neurosci 2010 1.14
27 Nanopesticides: guiding principles for regulatory evaluation of environmental risks. J Agric Food Chem 2014 1.12
28 Therapeutic nanoparticles in clinics and under clinical evaluation. Nanomedicine (Lond) 2013 1.11
29 Surface-induced changes in protein adsorption and implications for cellular phenotypic responses to surface interaction. Biomaterials 2006 1.10
30 In vitro developmental toxicity test detects inhibition of stem cell differentiation by silica nanoparticles. Toxicol Appl Pharmacol 2009 1.02
31 Nanomaterial categorization for assessing risk potential to facilitate regulatory decision-making. ACS Nano 2015 1.01
32 Protein fibrillation and nanoparticle interactions: opportunities and challenges. Nanoscale 2013 1.00
33 Activation of stress-related signalling pathway in human cells upon SiO2 nanoparticles exposure as an early indicator of cytotoxicity. J Nanobiotechnology 2011 0.97
34 Nanoscale reference materials for environmental, health and safety measurements: needs, gaps and opportunities. Nanotoxicology 2012 0.94
35 Cationic nanoparticles induce caspase 3-, 7- and 9-mediated cytotoxicity in a human astrocytoma cell line. Nanotoxicology 2010 0.93
36 Genotoxicity evaluation of amorphous silica nanoparticles of different sizes using the micronucleus and the plasmid lacZ gene mutation assay. Nanotoxicology 2010 0.91
37 Elution of labile fluorescent dye from nanoparticles during biological use. PLoS One 2011 0.90
38 Phase behavior of aqueous polyion-surfactant ion complex salts: effects of polyion charge density. J Phys Chem B 2007 0.87
39 Protein corona affects the relaxivity and MRI contrast efficiency of magnetic nanoparticles. Nanoscale 2013 0.86
40 Internal benchmarking of a human blood-brain barrier cell model for screening of nanoparticle uptake and transcytosis. Eur J Pharm Biopharm 2011 0.85
41 Intracellular localisation, geno- and cytotoxic response of polyN-isopropylacrylamide (PNIPAM) nanoparticles to human keratinocyte (HaCaT) and colon cells (SW 480). Toxicol Lett 2010 0.85
42 Effect of natural organic matter on cerium dioxide nanoparticles settling in model fresh water. Chemosphere 2010 0.85
43 Formation and characterization of the nanoparticle-protein corona. Methods Mol Biol 2013 0.84
44 Influence of the physiochemical properties of superparamagnetic iron oxide nanoparticles on amyloid β protein fibrillation in solution. ACS Chem Neurosci 2013 0.82
45 Is the toxic potential of nanosilver dependent on its size? Part Fibre Toxicol 2014 0.81
46 The protein corona mediates the impact of nanomaterials and slows amyloid beta fibrillation. Chembiochem 2013 0.80
47 Molecular basis of cell-biomaterial interaction: insights gained from transcriptomic and proteomic studies. Biomaterials 2006 0.80
48 The need for in situ characterisation in nanosafety assessment: funded transnational access via the QNano research infrastructure. Nanotoxicology 2012 0.79
49 Cytotoxic effects in 3T3-L1 mouse and WI-38 human fibroblasts following 72 hour and 7 day exposures to commercial silica nanoparticles. Toxicol Appl Pharmacol 2012 0.79
50 Surface-induced cell signaling events control actin rearrangements and motility. J Biomed Mater Res A 2010 0.78
51 How should the completeness and quality of curated nanomaterial data be evaluated? Nanoscale 2016 0.78
52 Ionic surfactants with polymeric counterions. Adv Colloid Interface Sci 2008 0.77
53 Paracrine signalling of inflammatory cytokines from an in vitro blood brain barrier model upon exposure to polymeric nanoparticles. Analyst 2013 0.77
54 Brushlike interactions between thermoresponsive microgel particles. Phys Rev Lett 2010 0.76
55 A TEM protocol for quality assurance of in vitro cellular barrier models and its application to the assessment of nanoparticle transport mechanisms across barriers. Analyst 2015 0.76
56 Preparation, characterization of NIPAM and NIPAM/BAM copolymer nanoparticles and their acute toxicity testing using an aquatic test battery. Aquat Toxicol 2009 0.75
57 Comment on "Gelation of microemulsions and release behaviour of sodium salicylate from gelled microemulsions" [Eur. J. Pharm. Biopharm. 71 (2009) 297]. Eur J Pharm Biopharm 2009 0.75
58 Gelled polymerizable microemulsions. 2. Microstructure. Langmuir 2008 0.75
59 Plum-pudding gels as a platform for drug delivery: understanding the effects of the different components on the diffusion behavior of solutes. J Phys Chem B 2007 0.75
60 Chemical shift imaging of molecular transport in colloidal systems: visualization and quantification of diffusion processes. J Colloid Interface Sci 2006 0.75
61 Gelled polymerizable microemulsions. 1. Phase behavior. Langmuir 2007 0.75